The 2008 Lasker-Koshland Award will be presented to Stanley Falkow, one of the legendary figures in the history of microbiology research. Falkow's many contributions remade the way we think about bacterial pathogens, antibiotic resistance, and infectious disease.
Achievement Award in Medical Science is to be presented to Stanley Falkow, the Cahill Professor of Microbiology and Immunology at Stanford University School of Medicine. Dr. Falkow has been the single most important figure in the analysis of bacterial pathogens over the past 50 years. His influence has shaped several fields of research involving the pathogenesis and drug resistance of disease-causing bacteria. This influence is the result of both breakthrough scientific results and philosophical discourses on what constitutes a pathogen. Many of the advances associated with his name have been completely internalized by contemporary microbiologists making it easy to forget that these results contradicted the scientific orthodoxy of their time. Indeed, very few scientists are such obvious choices for an award that is meant to be given to "scientists whose contributions to research are of unique magnitude and have immeasurable influence on the course of science, health, or medicine, and whose professional careers have engendered within the biomedical community the deepest feelings of awe and respect." Dr. Falkow's work has had a major impact on the discovery and visualization of extrachromosomal DNA in bacteria, the mechanism of acquisition of simultaneous resistance to multiple antibiotics, the mechanism of gene transposition, and the identification of bacterial virulence proteins. He then taught an entire field how to identify and analyze bacterial proteins that cause disease and manipulate host cells. His deep understanding of infectious diseases, remarkable for a scientist without a degree in medicine, has infiltrated the psyche of an entire field-so much so, in fact, that he is considered a mentor by virtually every researcher trying to understand the molecular basis for how bacterial pathogens cause disease. He is the direct intellectual descendant of the founders of microbiology; his impact can only be rightly compared to that of the original microbe hunters of the late 19 th and early 20 th centuries.
Extrachromosomal DNA and Antibiotic Resistance
In the 1950s and early 1960s, investigators working on laboratory strains of Escherichia coli dominated the field of bacterial genetics. Genetic evidence had been obtained for the existence of extrachromosomal elements, such as temperate bacteriophages and plasmids, and the analysis of these elements allowed the first molecular insights into the mechanisms of DNA replication and recombination, as well as the identification of the first genetic regulatory circuits. Originally called "episomes" by Jacob and Wollman, this term eventually became synonymous with plasmids before falling into disuse. The E. coli sex factor F was the first plasmid described, and its ability to pick up and transfer pieces of the bacterial chromosome was under intensive study. As plasmid transfer was termed conjugation, and sex in higher organisms showed strong species barriers, the titillating linguistics describing this process seemed to suggest that plasmid transfer only occurred between closely related bacterial species.
No one had directly isolated plasmids at that time. Indeed, when Stanley Falkow began studying pathogenic Salmonella and Shigella bacterial species, it had still not been demonstrated that plasmids were composed of DNA. Working with Lou Baron at Walter Reed Army Institute of Research, Falkow discovered that an F factor containing lac chromosomal DNA could be transferred to the unrelated Serratia marsescens species (Falkow et al., 1961) . The significance of this heretical observation was not lost on Falkow. He was well acquainted with recent literature on speciation using DNA base content, which showed that different species had a different guanine-cytosine (G+C) base content, allowing separation of DNA on cesium chloride (CsCl) gradients. During a short but productive stint in Julius Marmur's laboratory at Brandeis University, Falkow's discovery that the G+C base content of Serratia was very different from that of Salmonella was an important breakthrough. He could separate Salmonella DNA from that of Serratia and found that the F factor had a buoyant density different from that of the DNA of either species on CsCl gradients. Plasmids could now be isolated, analyzed, and dissected for the first time, and indeed they were composed of DNA. His observation that Proteus mirabilis has a G+C content that was even more distinct from that of E. coli (38% compared to 50% for E. coli) facilitated the next set of experiments that changed forever our perception of acquired antibiotic resistance in bacteria.
Falkow was not the only one thinking along the lines of interspecies transfer of DNA. Watanabe and Fukasawa had strong evidence that antibiotic-resistant strains of enterobacteria emerging in Japanese clinics had resulted from the transfer of plasmids, perhaps from unrelated bacterial species. Falkow turned his attention to these newly described plasmids, called R factors, and demonstrated that the same techniques used for F factor could be used to isolate and characterize antibiotic resistance elements (Falkow et al., 1966) . After transferring the resistance phenotype from E. coli strains to Proteus, Falkow showed that the resistance factors were plasmids that could be clearly visualized as satellite bands separate from Proteus chromosomal DNA on CsCl gradients. Consistent with Watanabe's observation that resistance was lost after treatment with acridine, a DNA intercalating reagent that "cured" the plasmid, the satellite bands disappeared in the presence of the chemical. Even more interesting was the nature of multiple antibiotic resistance that could be transferred between bacterial strains. Density gradients of these resistant strains sometimes showed multiple satellite bands or "shoulders" on peaks of other DNA species. If spontaneous variants that had lost one or more antibiotic resistance phenotypes were analyzed, peaks would lose intensity and the presence of shoulders would become more evident. Therefore, antibiotic resistant strains had multiple plasmids conferring this resistance. The loss of resistance was not due to mutation but was due to the spontaneous loss of plasmid DNA encoding drug resistance elements. Most importantly, the acquisition of resistance to multiple drugs was due to plasmid transfer between potentially unrelated bacterial species. The spread of antibiotic resistance was due to the promiscuous sexuality of bacteria and the transferable R factor plasmids they harbored.
It is often difficult to convey to students the mysteries leading up to results or to frame the importance of experiments that appear simple in comparison to today's technology. With the discovery of antibiotics, it had been thought that all infectious diseases having a bacterial cause could be cured with chemotherapeutics, and there was no reason to discourage unfettered use of antibiotics. The development of antibiotic-resistant microorganisms may have been predicted, but the nature of resistance was perceived at that time to be the result of spontaneous mutations that eliminated the target sites of antibiotics. With the isolation and characterization of R factor DNA by Falkow, a new model for antibiotic resistance had to be developed. Antibiotic resistance was found on extrachromosomal elements, and it was transferable, promiscuous, crossed species barriers, and in certain circumstances had variable genetic stability. The most widespread antibiotic use was in livestock to "enhance" growth. Falkow realized that bacteria harbored by livestock were largely antibiotic resistant, and as the species barriers for transfer of resistance were looser than in higher organisms, resistance of pathogens to antibiotics could easily be acquired from bacteria in livestock (Falkow, 1970) . In addition to the clinical relevance of these findings, the ability to easily isolate plasmids that carried readily selectable genetic markers, such as antibiotic resistance, provided a critical first step in the dawning of the age of recombinant DNA technology.
What was the nature of the antibiotic resistance genes on plasmids? The ampicillin resistance gene encodes a β-lactamase, and in the early 1970s, the technology to identify sequence relations between regions of DNA required using electron microscopy (EM) and single-strand specific nucleases to map regions of homology (heteroduplex mapping), a technique developed in Falkow's laboratory by Jorge Crosa (Crosa et al., 1973) . Falkow became the laboratory's EM technician, a title he has proudly worn throughout his career. By 1974, a large number of seemingly unrelated plasmids that encoded ampicillin resistance had accumulated in his laboratory, and heteroduplex mapping indicated that the gene encoding this resistance was identical in these otherwise nonhomologous plasmids. Some process had allowed insertion of this gene in seemingly random sites in various plasmid DNAs. In a breakthrough study, Jacob and Hedges showed that these insertions were due to gene transpositions. Very rapidly, Falkow's graduate students Fred Heffron and Ron Gill demonstrated that transposons encode their own enzymatic machinery for gene movement, and they provided the key experiments pointing to a molecular model for gene transposition (Gill et al., 1978) . Through the isolation of deletion mutants and complementation analysis, they showed that transposition of the ampicillin-resistance transposon (now called Tn3) between plasmids involved a replication step in which the donor and target plasmids are fused, generating a duplication of the transposon at the junctions between the fused plasmids. A protein missing in one of these deletion mutants (now called resolvase) probably resolved this intermediate, completing the transposition reaction. This experiment formed the basis for the now famous "Shapiro Model" for gene transposition. Interestingly, transposable antibiotic resistance elements of this sort would allow Falkow's laboratory to begin to dissect bacterial proteins important for virulence.
Molecular Cloning and Bacterial Virulence Proteins
Throughout the course of his studies on antibiotic resistance, Falkow never lost sight of his original reason for working on plasmids. He considered these DNA elements tools to perform conjugation experiments that allowed genetic manipulation of bacterial pathogens. The problem with this approach was that conjugative manipulation of genetic markers was not a sufficiently powerful tool to allow one to decipher what proteins pathogens encode to cause disease. For Falkow, therefore, plasmids became interesting biological entities to study in-and-of themselves, while waiting for technology that would allow sophisticated analysis of pathogens. His re-entry into the world of the microbiology of pathogens started slowly, following up on a conversation in the late 1960s with veterinary microbiologist H.W. Smith Nature had "cloned" virulence-associated genes, and these could now be studied. Unfortunately, these plasmids were still rather large entities, and there were no genetic tools available to allow the same kind of dissection of virulence-associated genes that workers had used to analyze regulatory circuits in the K-12 strain of E. coli. So it was with great excitement that Falkow participated in the "Delicatessen Dialogs" leading to Chang's, Cohen's, and Boyer's plan to construct the first synthetic plasmids using restriction endonucleases (Cohen et al., 1973) . The ability to purify and analyze DNA fragments at will by molecular cloning now meant that any gene involved in bacterial pathogenesis could be analyzed. So, it was not long before Falkow's laboratory became the first to identify and clone enterotoxin genes in work performed by Magdelene So and Walter Dallas (Dallas and Falkow, 1979; So et al., 1976) .
In the late 1970s, the study of bacterial pathogenesis was almost totally synonymous with the analysis of exotoxins, proteins secreted by bacteria that have targets either on the surface or within host cells. Secondary to toxin analysis was the study of bacterial adhesion to host cells, which was primarily limited to pili, proteinaceous appendages on the surface of Gram-negative organisms. These were obvious targets for the first recombinant DNA experiments, but the discovery of these determinants relied on their purification as biochemical entities prior to their genes being isolated. The use of wholly genetic approaches to identify previously unknown bacterial virulence proteins had rarely been attempted in any systematic fashion. One such attempt by Falkow in the 1960s produced interesting data on the role of lipopolysaccharide (LPS) in establishing disease, but there were clearly other determinants of virulence that he could not identify. In fact, he dropped the traditional genetic approach for analyzing pathogenesis when he received little encouragement from colleagues to continue this avenue of attack. Another problem with traditional genetic techniques was that they were limited to microorganisms, such as E. coli and Salmonella, that had a long history of genetic analysis. But there was a very wide world of bacterial pathogens that were medically important that could not be studied this way, some of which could not even be grown in pure culture. Once recombinant DNA technology and transposable genetic elements that could be inserted in a wide range of organisms became available, the door swung open to allow investigation of bacterial pathogens that previously had been intractable to genetic analyses.
Through a coalescence of proof-ofprinciple and chutzpah, Falkow began to work on Yersinia pestis and Bordetella pertussis. Y. pestis is an enteric bacterium related to E. coli, so it seemed like a small technological step to move to this pathogen. But the bug causes bubonic plague! This was Falkow's signal that it was time for everyone in the field to think about studying the most virulent organisms with the same strategies used to study the less dangerous ones. B. pertussis, the causative agent of whooping cough, was another matter altogether. The bacterium grows poorly, there were few culture media available that allowed reproducible passage, and genetic analysis of this microorganism seemed hopeless at the time. Fortunately, Falkow found two risk-taking PhD candidates who rose to the challenge. With Dan Portnoy working on Y. pestis and Allison Weiss working on B. pertussis, the spectrum of bacterial pathogens being studied in his lab was suddenly very wide.
In quick order, Portnoy demonstrated that the critical virulence proteins of Y. pestis are encoded on a plasmid, and he isolated insertion mutations that led to the discovery of a dedicated secretion system (now called a Type III system) that translocates Yersinia proteins into host cells (Portnoy et al., 1983 ). Furthermore, he was able to identify the very proteins that were later shown to move into the host cell. Working on B. pertussis, Weiss first established that transposable antibiotic resistance elements could be used to dissect this organism genetically and then uncovered a new global regulatory system that was later shown to involve a histidine kinase cascade (Weiss and Falkow, 1984) . What had previously been described as "virulence factors" now became real entities in the hands of Falkow and coworkers. Although each bacterial pathogen has its special challenges, and many require huge efforts to obtain small amounts of instructive information, the fear of analyzing these agents was gone. Most importantly, any kind of genetic screen or selection seemed within reason, allowing an understanding of bacterial pathogenesis that had seemed impossible even when Falkow was a mid-career scientist.
With this background, Falkow decided that it was time to both use the host and study it. In part this reflected the interests of those attracted to his lab, but it was also a direct outgrowth of the new sorts of assays being used in his laboratory, which allowed analysis of the uptake and manipulation of cultured cells. The ability to identify the important bacterially encoded proteins that manipulate target cells meant that workers could use bacterial proteins to interrogate host cells. Using host cells as selective agents, his lab was able to identify and analyze bacterial proteins that mediate the adhesion and uptake of pathogens into host cells (Isberg and Falkow, 1985) . Furthermore, host cells themselves became a new growth medium for bacteria. Strategies were developed in the lab to identify proteins that were selectively expressed when bacteria were associated or internalized into host cells and to analyze the impact in animal models of mutations that prevented bacteria from making these proteins. But what was the host doing to either collaborate with or antagonize these proteins, both at the cellular and organismal levels?
To better appreciate how the pathogen causes disease, Falkow's laboratory had to directly analyze the response of host cells to the infecting organism. This led to the idea that the disease process is a result of fine-tuning contrasting strategies of stealth, destruction, and misregulation. Stealth was recognized when his group analyzed entry of Salmonella into cells overlying intestinal lymph nodes or when they observed that the microorganism-generated responses in cultured mammalian cells mimicked the effects of growth factors (Jones et al., 1994) . Destruction could be seen when the same bacteria entering lymph nodes also destroyed intestinal epithelial cells. Misregulation was documented when his laboratory discovered that the CagA protein of Helicobacter pylori, the causative agent of gastric ulcers, disrupted epithelial junctions (Figure 1) (Amieva et al., 2003) .
The Zen of Bacterial Pathogenesis
Listing the accomplishments of Stanley Falkow and his laboratory does not reflect the true importance of Falkow to the field of microbiology. In part, his impact has been amplified by the impressive careers of the many students and postdoctoral fellows whom he trained. Even more striking is his role as the premier philosopher-scientist of the field of microbial pathogenesis, reflecting his broad knowledge of infectious diseases, incredible intuition, uncanny ability to understand what the next interesting question will be, and ability to formulate experiments that were often years ahead of the thinking of the field. For instance, today when the complete genome sequence of a pathogen is determined, the first order of business is to analyze its G+C content, looking for regions that vary markedly from the rest of the coding sequence. These regions are marked as "islands" harboring genes obtained by horizontal transfer that may encode proteins involved in the pathogenesis of disease. This concept of pathogenicity islands is an extension of Falkow's original experiments in the 1960s showing that there were discontinuities in the G+C content of F factor DNA, which he supposed might be indicators of mobile genetic elements.
Finally, an effective scientific leader has a flexible attitude toward his own ideas, particularly in light of the rapid pace of research. Perhaps the treatise that is most closely associated with Falkow is his "Molecular Koch's Postulates" (Falkow, 1988) . This model was meant to increase the rigor of the field; he argued that if a researcher wants to claim that a protein is involved in the disease process, its gene should be knocked out and the mutant should be tested in an animal model of infection. Only if the mutant shows a defect in some process associated with disease should the researcher feel safe in calling it a virulence factor. It is a mark of his character as a scientist that he is the one who has published the most detailed and scathing critique of the shortcomings of this model, in a paper that is probably the best summary of the complexities inherent in the analysis of pathogens (Falkow, 2004) .
The remarkable career of Stanley Falkow has forever changed the analysis of bacterial pathogens. His lifelong interest in microbes, his ability to straddle the worlds of molecular biology and infectious diseases, his enthusiastic and charismatic personality that is an excellent tool for recruiting talented scientists to the field of microbiology, and his amazing ability to see into the future put him at a level of accomplishment and influence that is rarely encountered in any field of research.
